Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli <i>et al</i>.

Romão, Vasco C; Cruz-Machado, Ana Rita; Fonseca, João Eurico

Response to: 'The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients' by Favalli et al.

Romão, Vasco C; Cruz-Machado, Ana Rita; Fonseca, João Eurico.

Afiliación

Romão VC; Rheumatology Department, Hospital de Santa Maria, CHULN, Lisbon Academic Medical Centre, Lisbon, Portugal.
Cruz-Machado AR; Rheumatology Research Unit, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Fonseca JE; Rheumatology Department, Hospital de Santa Maria, CHULN, Lisbon Academic Medical Centre, Lisbon, Portugal.

Ann Rheum Dis ; 80(5): e76, 2021 05.

Article en En | MEDLINE | ID: mdl-32561609

Asunto(s)

Antimaláricos; Artritis Reumatoide; COVID-19; Antimaláricos/uso terapéutico; Artritis Reumatoide/tratamiento farmacológico; Humanos; Hidroxicloroquina/uso terapéutico; SARS-CoV-2

Palabras clave

arthritis, rheumatoid; epidemiology; hydroxychloroquine; lupus erythematosus, systemic

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / COVID-19 / Antimaláricos Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2021 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google